Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

UH Seidman Cancer Center Experts to Present Data at 52nd ASCO Annual Meeting

Share
Facebook
Twitter
Pinterest
LinkedIn
Email
Print

Presentations Highlight the ASCO 2016 theme, “Future of Patient-Centered Care and Research”

Presentations by Researchers from University Hospitals Seidman Cancer Center and Case Western Reserve University School of Medicine at ASCO 2016 include:

Individualizing Care for Older Adults Across the Cancer Care Continuum: Emerging Evidence and Collective Wisdom
Education Session: Cynthia Owusu, MD, MS
Presentation: Assessing and Minimizing Functional Decline During and After Chemotherapy
June 4 8:00 a.m. – 11:00 a.m., McCormick Place, S103
https://iplanner.asco.org/am2016/#/session/11368

Predicted benefit of alternative post-treatment surveillance strategies in stage II and III colon cancer survivors
Abstract 3623: Johnie Rose, MD, PhD
Poster Session: Gastrointestinal (Colorectal) Cancer
June 4, 8:00 – 11:30 a.m., Hall A
http://abstract.asco.org/176/AbstView_176_170242.html

Preliminary Results from KEYNOTE-055: Pembrolizumab after Platinum and Cetuximab Failure in Head and Neck Squamous Cell Carcinoma (HNSCC)
Abstract 6011: Michael Gibson, MD, PhD
Session: Clinical Science Symposium: Harnessing the Immune System in Head and Neck Cancer: Evolving Standards in Metastatic Disease
June 4, 8:00 – 11:30 a.m., Hall A
http://abstract.asco.org/176/AbstView_176_166094.html

Randomized phase II study of cisplatin and etoposide versus temozolomide and capecitabine in patients (pts) with advanced G3 non-small cell gastroenteropancreatic neuroendocrine carcinomas (GEPNEC): A trial of the ECOG-ACRIN Cancer Research Group (EA2142)
Abstract TPS4149: Jennifer Eads, MD
Poster Session: June 4, 8:00 – 11:30 a.m., Hall A
http://abstract.asco.org/176/AbstView_176_171297.html

An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG oncology/RTOG 0525 and 0825
Abstract 2007: Jill Barnholtz-Sloan, PhD
Oral Abstract Session: Central Nervous System Tumors
June 5, 8:00 – 11:00 a.m., S100a
http://abstract.asco.org/176/AbstView_176_170230.html

Opportunities for Collective Decision-Making in Clinical Practice
Education session: Neal Meropol, MD
Presentation: Are Clinical Trials Right for Me? Creating an Online Decision-Making Tool for Patients
June 5, 11:30 – 11:50 a.m., S404
https://iplanner.asco.org/am2016/#/session/11195

HCRN GU14-188: Neoadjuvant pembrolizumab (P) and gemcitabine (G) with or without cisplatin (C) in muscle invasive urothelial cancer (MIUC)
Abstract TPS4578: Chris Hoimes, DO
Poster Session: Genitourinary (Nonprostate) Cancer
June 6, 1:00 – 4:30 p.m., Hall A
http://abstract.asco.org/176/AbstView_176_170957.html

Predictors of unplanned hospitalizations among older adults receiving cancer chemotherapy
Abstract 10057: Cynthia Owusu, MD, MS
Poster Session: Patient and Survivor Care
June 6, 1:00 p.m. – 4:30 p.m., Hall A
http://abstract.asco.org/176/AbstView_176_171200.html

Complex association between social support and chemotherapy-related toxicities in older cancer patients
Abstract 10036: Cynthia Owusu, MD, MS
Poster Session: Patient and Survivor Care
June 6, 1:00 p.m. – 4:30 p.m., Hall A
http://abstract.asco.org/176/AbstView_176_162843.html

Phase I/II study of niraparib plus pembrolizumab in patients with triple-negative breast cancer or recurrent ovarian cancer
Abstract TPS5599: Shaveta Vinayak, MD
Poster Session: Gynecologic Cancer
June 6, 1:00 p.m. – 4:30 p.m., Hall A
http://abstract.asco.org/176/AbstView_176_165149.html

 

About University Hospitals
Founded in May 1866, University Hospitals serves the needs of patients through an integrated network of 18 hospitals, more than 40 outpatient health centers and primary care physician offices in 15 counties throughout Northeast Ohio. At the core of our $4 billion health system is University Hospitals Case Medical Center, ranked among America’s best hospitals by U.S. News & World Report. The primary affiliate of Case Western Reserve University School of Medicine, UH Case Medical Center is home to some of the most prestigious clinical and research programs in the nation, including cancer, pediatrics, women's health, orthopaedics, radiology, neuroscience, cardiology and cardiovascular surgery, digestive health, transplantation and genetics. Its main campus includes UH Rainbow Babies & Children's Hospital, ranked among the top children’s hospitals in the nation; UH MacDonald Women's Hospital, Ohio's only hospital for women; and UH Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center at Case Western Reserve University. UH is the second largest employer in Northeast Ohio with 26,000 employees. For more information, go to www.UHhospitals.org.

Share
Facebook
Twitter
Pinterest
LinkedIn
Email
Print